Noticias y Actividades de BioNano Genomics
Presencia
Sede: Estados Unidos
BioNano Genomics es una empresa que cotiza bajo el símbolo de cotización BNGO (US).
Ejecutivos
Ver el organigrama con sus 21 ejecutivos principales
Biografías más buscadas en BioNano Genomics
- Albert Luderer, Interim Chief Executive Officer and Chairman of th...
- David Barker, Director
- Kristiina Vuori, Director
Recientes movimientos de ejecutivos en BioNano Genomics
- Alka Chaubey, Chief Medical Officer, ha dejado la empresa (noticia publicada el 6 de julio de 2026).
- Alex Hastie, se ha incorporado a la empresa como Chief Scientific Officer (noticia publicada el 25 de junio de 2026).
- Christopher Twomey que ha sido Director, pasa a ser Lead Independent Director (noticia publicada el 8 de mayo de 2026).
Haga clic aquí para ver otros movimientos en BioNano Genomics
Crear su alerta
para seguir los movimientos de los ejecutivos en BioNano Genomics.
Biotecnología
BioNano Genomics tiene 2.428 competidores entre los que se incluyen Lonza (Suiza), Vertex Pharmaceuticals (Estados Unidos) y Eurofins (Luxemburgo).
Popular M&A news in Biotecnología
- Eli Lilly has announced the acquisition of AtaiBeckley (publicado el 17 de julio de 2026).
- GSK ha Nuvalent adquirido (publicado el 17 de julio de 2026).
- Clearside Biomedical has gone out of its bankruptcy protection (publicado el 15 de julio de 2026).
Otros contactos sugeridos en el sector Biotecnología
Noticias
Últimos comunicados de prensa de BioNano Genomics
- Bionano Announces Presentation of OGM Utility Across Key Research Applications at the Association for Molecular Pathology Annual Meeting | Bionano Genomics, Inc.
- Bionano Reports Third Quarter 2023 Results and Highlights Recent Business Progress | Bionano Genomics, Inc.
- Bionano Announces Presentation of OGM Utility Across Key Applications at the American Society of Human Genetics (ASHG) Annual Meeting | Bionano Genomics, Inc.
- Bionano to Report Third Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 8, 2023 | Bionano Genomics, Inc.
- Thompson and Thompson Genetics and Genomics in Medicine Includes OGM in Latest Edition, Notes Workflow’s Performance and Ability to Detect More SVs than LRS at Lower Cost | Bionano Genomics, Inc.
- Bionano to Present at the 2023 Stifel Healthcare Conference | Bionano Genomics, Inc.
- Largest Study of Mendelian Disease Highlights how OGM, alongside other Techniques, May Enhance Success Rates in Identifying Molecular Causes of Genetic Disease | Bionano Genomics, Inc.
- Bionano Announces Peer-Reviewed Publication on the Utility of Combining OGM and WES for Evaluation of Pediatric Leukemia | Bionano Genomics, Inc.
- Bionano Announces Publication Demonstrating Utility of OGM as an Alternative to KT and CMA for Evaluating CRISPR-Edited Cells as Part of Stem Cell Therapy Development | Bionano Genomics, Inc.
- Bionano Announces Second OEM Partner has Received China NMPA Approval for DNA Extraction and Labeling Products for IVD Use of OGM in Reproductive Health | Bionano Genomics, Inc.
- View more press releases Close
Redes sociales sobre BioNano Genomics
- BioNano Genomics en Wikipedia, Google News y Yahoo Finance
- BioNano Genomics en LinkedIn, Twitter y YouTube
